Neuromyelitis optica (NMO) is an inflammatory disorder of the central nervous system (CNS) that primarily affects the optic nerves and spinal cord. Recent research has indicated that NMO is a distinct disorder form multiple sclerosis, where CNS injury is driven by an autoimmune antibody response against aquaporin-4 (AQP4) localized on astrocyte foot processes. Due to significant risk for permanent neurologic impairment, rapid diagnosis and appropriate therapy are essential. This presentation will examine current treatment paradigms in NMO and address novel directions for future therapy.
Relation is Part of
NANOS 2013: Treatment in Neuro-Ophthalmology - That's Hot!
Contributor Primary
Galetta, Steven
Contributor Secondary
Quiros, Peter A
Publisher
Spencer S. Eccles Health Sciences Library, University of Utah
